Yingxia Liu

Active 2011–2025

118
Papers
21,958
Citations
55
h-index
109
i10-index

Citations

Citations per year for Yingxia Liu1989: 1 citations1991: 1 citations2005: 1 citations2006: 1 citations2009: 1 citations2010: 2 citations2014: 2 citations2015: 7 citations2016: 16 citations2017: 25 citations2018: 29 citations2019: 169 citations2020: 3,905 citations2021: 2,376 citations2022: 972 citations2023: 463 citations2024: 566 citations2025: 245 citations2026: 7 citations1990: no citations, so this year is not shown1992–2004: no citations, so these years are not shown2007–2008: no citations, so these years are not shown2011–2013: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,226 citing papers, 18.3% of this breakdownUnited States: 2,212 citing papers, 18.2% of this breakdownUnited Kingdom: 658 citing papers, 5.4% of this breakdownIndia: 561 citing papers, 4.6% of this breakdownItaly: 493 citing papers, 4% of this breakdownCanada: 362 citing papers, 3% of this breakdownGermany: 357 citing papers, 2.9% of this breakdownIran: 283 citing papers, 2.3% of this breakdownFrance: 272 citing papers, 2.2% of this breakdownSpain: 262 citing papers, 2.2% of this breakdownAustralia: 239 citing papers, 2% of this breakdownSouth Korea: 204 citing papers, 1.7% of this breakdown
0%18.3%Other 33.2%

Fields

  • Medicine78%
  • Biochemistry, Genetics and Molecular Biology7.1%
  • Pharmacology, Toxicology and Pharmaceutics3%
  • Mathematics2.1%
  • Immunology and Microbiology2%
  • Computer Science1.8%
  • Other6%

Topics

  • COVID-19 Clinical Research Studies16.8%
  • SARS-CoV-2 and COVID-19 Research15.6%
  • Long-Term Effects of COVID-196.4%
  • SARS-CoV-2 detection and testing5.4%
  • COVID-19 epidemiological studies1.8%
  • COVID-19 and healthcare impacts1.5%
  • Other52.5%

Coauthors

All papers

Open in search
  1. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2019 cited by 612

  2. Global liver disease burdens and research trends: Analysis from a Chinese perspective

    Authors: , , , , , , , , , , , , , , , , , - Journal of Hepatology 2019 cited by 547

  3. Genesis, Evolution and Prevalence of H5N6 Avian Influenza Viruses in China

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Di Liu, George F. Gao - Cell Host & Microbe 2016 cited by 343

  4. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Science 2020 cited by 1,110

  5. Ultrasensitive DNA Origami Plasmon Sensor for Accurate Detection in Circulating Tumor DNAs

    Authors: , , , , , , , , , , , , , , , , - Laser & Photonics Review 2024 cited by 115

  6. Dominant subtype switch in avian influenza viruses during 2016–2019 in China

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marina Gulyaeva, George F. Gao, Jianjun Chen, Yi Shi, William J. Liu, Dong Chu, Yu Huang, Yingxia Liu, Lei Liu, Wenjun Liu, Quanjiao Chen, Weifeng Shi - Nature Communications 2020 cited by 190

  7. Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2020 cited by 2,670

  8. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2020 cited by 694

  9. CSH guidelines for the diagnosis and treatment of drug-induced liver injury

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wen Xie, Changqing Yang, Dong-liang Yang, Yanyan Yu, Minde Zeng, Li Zhang, Xinyan Zhao, Hui Zhuang - Hepatology International 2017 cited by 297

  10. The Anti-Oxidant and Antitumor Properties of Plant Polysaccharides

    Authors: , , , , - The American Journal of Chinese Medicine 2016 cited by 161

  11. HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical and Translational Hepatology 2018 cited by 165

  12. The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Structure 2020 cited by 205

  13. Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in cultured Vero cells

    Authors: , , , , , , , , , , - Phytotherapy Research 2020 cited by 132

  14. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2020 cited by 2,425

  15. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Engineering 2020 cited by 1,405

  16. COVID-19: Abnormal liver function tests

    Authors: , , , , , , , , , , , , , , , - Journal of Hepatology 2020 cited by 1,081

  17. Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - National Science Review 2020 cited by 279

  18. S-Allylmercaptocysteine improves alcoholic liver disease partly through a direct modulation of insulin receptor signaling

    Authors: , , , , , , , , , - Acta Pharmaceutica Sinica B 2020 cited by 61

  19. Harnessing stepping-stone hosts to engineer, select, and reboot synthetic bacteriophages in one pot

    Authors: , , , , , , , , , , , , , , , , , - Cell Reports Methods 2022 cited by 28

  20. Persistent Bacterial Coinfection of a COVID-19 Patient Caused by a Genetically Adapted Pseudomonas aeruginosa Chronic Colonizer

    Authors: , , , , , , , , , , , , , - Frontiers in Cellular and Infection Microbiology 2021 cited by 93

  21. Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B.1.1.529): a prospective cohort study from Shenzhen, China

    Authors: , , , , , , , , , - The Lancet Microbe 2023 cited by 57

  22. Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Emerging Microbes & Infections 2020 cited by 168

  23. Oxidative Stress in Stem Cell Aging

    Authors: , , , , - Cell Transplantation 2017 cited by 145

  24. Lycium barbarum polysaccharide attenuates alcoholic cellular injury through TXNIP-NLRP3 inflammasome pathway

    Authors: , , , , , - International Journal of Biological Macromolecules 2014 cited by 100